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Abstract
Background: Depression is a heterogeneous condition, with multiple possible
symptom‐profiles leading to the same diagnosis. Descriptive depression subtypes
based on observation and theory have so far proven to have limited clinical utility.
Aim: To identify depression subtypes and to examine their time‐course and prog-
nosis using data‐driven methods.
Methods: Latent transition analysis was applied to a large (N=8380) multi‐service
sample of depressed patients treated with cognitive behavioral therapy (CBT) in out-
patient clinics. Patients were classed into initial latent states based on their responses to
the Patient Health Questionnaire‐9 of depression symptoms, and transition probabilities
to other states during treatment were quantified. Qualitatively similar states were
clustered into overarching depression subtypes and we statistically compared indices of
treatment engagement and outcomes between subtypes using post hoc analyses.
Results: Fourteen latent states were clustered into five depression subtypes: mild
(2.7%), severe (9.8%), cognitive‐affective (23.7%), somatic (21.4%), and typical
(42.4%). These subtypes had high temporal stability, and the most common transi-
tions during treatment were from severe toward milder states within the same
subtype. Differential response to treatment was evident, with the highest im-
provement rate (63.6%) observed in the cognitive‐affective subtype.
Conclusion: Replicated evidence indicates that depression subtypes are temporally
stable and associated with differential response to CBT.
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1 | INTRODUCTION
Depression, a highly common mental health problem that affects ap-
proximately 264 million people worldwide (James et al., 2018), is char-
acterized by a wide range of symptoms, including cognitive (e.g.,
repetitive negative thoughts, suicidal ideas), affective (e.g., anhedonia,
avolition) and somatic (e.g., problems with sleep, psychomotor dis-
turbances) indicators. Despite a range of recommended, evidence‐based
treatment options including pharmacotherapy and various forms of
psychotherapy (National Institute for Health and Care Excellence, 2009),
only half of patients recover (Holtzheimer & Nemeroff, 2006; Khan et al.,
2012). This evidence suggests that currently available treatments are
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
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only moderately effective. However, an alternative argument is that
depression is a highly heterogeneous condition (Goldberg, 2011)—
potentially characterized by various subtypes—and clinical outcomes
could be improved if treatment was based on more precise assessments
of each individual's symptom profile (Fried, 2017).
It is widely acknowledged that current diagnostic systems often
fail to capture the underlying heterogeneity within a particular diag-
nostic label (Cuthbert & Insel, 2013). This is a particular issue for
depression, where—in theory—over 100 different combinations of
symptoms can result in the same unitary diagnosis of depression
(Zimmerman et al., 2015). Research investigating the effectiveness of
different treatments for different depression subtypes has offered
mixed results, limiting the use of classification systems for determining
the most appropriate treatment for a particular patient (Arnow et al.,
2015; Uher et al., 2011). In particular, subtyping concepts that are
derived from clinical observation and theory often have little empirical
support or prognostic utility (Haslam & Beck, 1994).
In recent years, data‐driven approaches, such as latent class
analysis (LCA) that aim to define depression subtypes based on
itemized scores in standardized questionnaires, without imposing any
theoretical constructs on the statistical model a priori (e.g., Putnam
et al., 2015; Ulbricht et al., 2015, 2018) have provided valuable in-
sights into different symptom profiles. However, LCA has been limited
to rigid clustering of patients into static classes, providing no indica-
tion of their temporal stability, or how different subtypes may respond
to treatment. Latent transition analysis (LTA) is an extension of LCA
which uses longitudinal data to explore transitions between classes
over time (Ni et al., 2017; Ulbricht et al., 2016). This technique is
better suited to examine how patients with different depression
subtypes respond to treatment, which is potentially informative for
personalized treatment planning.
In a recent demonstration, Catarino et al. (2020) applied LTA in a
large (N = 9,891) sample of patients who accessed internet‐enabled
cognitive behavioral therapy (CBT) for depression. The results classed
patients into seven distinctive depressive states, loading preferentially
on cognitive/affective versus somatic symptoms. Transition prob-
ability analysis revealed that patients starting in cognitive/affective
states typically do not transition to somatic states, and vice‐versa.
Although the distinction between cognitive/affective and somatic
symptoms in depression is well supported by the literature (Barton
et al., 2017; Carragher et al., 2009; Lee et al., 2012, 2014), this was the
first study exploring how patients in these two distinct states respond
to a highly standardized evidence‐based psychological treatment.
Importantly, Catarino et al. (2020) showed that patients who are
classified into somatic states were less likely to improve, and more
likely to be female, suffering from a long‐term physical illness, and
taking antidepressants (Catarino et al., 2020). Notwithstanding its
clinically informative results, this study was based on a sample of
patients who opted‐in to receive CBT via text messages. It is unclear if
patients who find this treatment modality acceptable may be sys-
tematically different to typical clinical samples who receive more
traditional in‐person therapy in healthcare settings. Thus, the gen-
eralizability of these findings to typical clinical samples is unknown.
The present study aimed to address a gap in knowledge concerning
the generalizability and clinical utility of depression subtyping based on
LTA methods. To this end, we applied the methods used by Catarino
et al. (2020) in a large multi‐service sample of depressed patients ac-
cessing routinely‐delivered CBT in community (outpatient) settings.
2 | METHODS
2.1 | Design and ethical approval
This naturalistic, retrospective, observational cohort study analyzed
practice‐based data collected between 2014 and 2017 across eight
National Health Service (NHS) trusts in England.1 Ethical approval for
the analysis of this data set was granted by the London City & East
NHS Research Ethics Committee (06/01/2016, Ref:15/LO/2200).
2.2 | Data sources and sample selection
All participating NHS Trusts offered psychological care as part of the
Improving Access to Psychological Therapies (IAPT) program. IAPT
services deliver evidence‐based psychological interventions for
common mental health disorders within a stepped‐care model
(Clark, 2011). In this system, most patients are initially referred for
brief (≤8 sessions), low‐intensity guided self‐help interventions.
Those who remain symptomatic, or who initially present with more
severe and complicated problems, are referred for high intensity
psychotherapies (up to 20 sessions), including CBT, person‐centered
experiential counseling or interpersonal psychotherapy as re-
commended by clinical guidelines (National Institute for Health and
Care Excellence, 2011). IAPT interventions are highly standardized,
protocol‐driven, and delivered by practitioners qualified to a post‐
graduate level under regular supervision (National Collaborating
Center for Mental Health, 2018).
Fully anonymised clinical records were obtained for a sample of
44,593 patients across all participating services, who were referred
for and attended at least one session of CBT. To maximize compar-
ability with prior research applying LTA, the sample was based on a
subset of cases that met the following criteria: (a) patients presented
with depression/affective disorder as their primary problem ac-
cording to clinical records; (b) accessed face‐to‐face high intensity
CBT in an outpatient clinic setting; (c) had at least one depression
measure available; and (d) had sessional depression measures from
no more than 10 sessions in total, to ensure the computational de-
mand was manageable (70% of the sample had ≤10 measures). In this
way, the only methodological difference between this study and
1South West Yorkshire Partnership NHS Foundation Trust, North East London NHS
Foundation Trust, Whittington Health NHS Trust, Barnet Enfield and Haringey Mental
Health Trust, Pennine Care NHS Foundation Trust, Cheshire and Wirral Partnership NHS
Foundation Trust, Cambridgeshire and Peterborough NHS Foundation Trust, Humber NHS
Foundation Trust.
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Catarino et al. (2020), was that the present sample received tradi-
tional in‐person CBT rather than internet‐enabled CBT. The selected
study sample consisted of 8380 patients (see Table 1 for sample
characteristics). Study flowchart with reasons for exclusion is re-
ported in the Supplemental Material.
2.3 | Measures
Patients accessing IAPT services complete standardized ques-
tionnaires at the start of each session, as part of routine outcome
monitoring. The Patient Health Questionnaire‐9 (PHQ‐9) is a nine‐
item questionnaire assessing symptoms of major depression, including
affective (items 1, 2), cognitive (items 6, 7, 9) and somatic domains
(items 3, 4, 5, 8). Each item is rated on a 0–3 scale (0 = “not at all,”
3 = “nearly every day”), with a total score between 0 and 27 (Kroenke
et al., 2001). A cut‐off point of ≥10 has been recommended to detect
clinically significant depression symptoms (Kroenke et al., 2001). The
GAD‐7 is a seven‐item questionnaire assessing symptoms of gen-
eralized anxiety. Each item is also rated from 0 to 3, producing a total
score between 0 and 21 (Spitzer et al., 2006). A cut‐off point of ≥8 has
been recommended to identify clinically significant anxiety symptoms
(Kroenke et al., 2007).
Additional anonymized demographic and clinical data included
age, gender, ethnicity, employment status, medication status, pre-
sence of a long‐term physical condition, and baseline impaired
functioning severity measured using the Work and Social Adjustment
Scale (WSAS; Mundt et al., 2002).
2.3.1 | Outcomes of interest
To allow comparison with the study by Catarino et al. (2020),
treatment outcomes were assessed according to the same criteria for
treatment engagement and reliable change. An additional dropout
outcome was also assessed in the current study. Patients were
deemed treatment engagers if they attended two or more treatment
sessions. Consistent with outcome definitions used routinely by IAPT
services to examine reliable change (National Collaborating Center
for Mental Health, 2018), reliable improvement was present when at
least one of the two primary outcome measures showed a statisti-
cally reliable reduction in scores (≥6 points on the PHQ‐9 and/or ≥4
points on the GAD‐7), in the absence of a reliable increase in the
other measure (Gyani et al., 2013). Reliable deterioration was re-
corded when at least one of the measures showed a reliable increase
in scores (≥6 points on the PHQ‐9 and/or ≥4 points on the GAD‐7).
Finally, patients were classed by therapists as having dropped out if
they unilaterally discontinued treatment and had an unplanned
ending to their episode of care.
2.4 | Statistical analysis
2.4.1 | Latent Markov modeling procedure
Analyses were conducted in R (version 3.6.1) using the package
LMest (Bartolucci et al., 2017). Following the procedure reported
in Catarino et al. (2020), a Hidden Markov Model (HMM) was
applied to the longitudinal item‐level PHQ‐9 data from the entire
sample (N = 8380) to estimate latent depressive subtypes and the
corresponding state‐to‐state transition probabilities. Unlike
Catarino et al. (2020), we decided to interpret the model that had
best empirical support (smallest Bayesian Information Criterion
value), rather than to identify a reduced state model that aimed
to balance fit and interpretability. This was to ensure complete
objectivity in model selection and to explore differences and/or
similarities between states and transitions with greater granu-
larity. After determining the optimal model, global decoding was
performed to approximate a depressive state for each patient at
every time point. Transition probabilities were extracted and
plotted to explore between‐state transitions in response to
treatment.
2.4.2 | Post‐hoc analyses of state groupings
Qualitatively similar states were grouped into a smaller set of
overarching depression subtypes. Patients' starting states were
compared using post‐hoc analyses in relation to treatment engage-
ment, duration and posttreatment clinical outcomes. These analyses
were based on chi‐square (for binary outcomes) and analysis of
variance (for continuous outcomes). In addition, we applied logistic
regressions to investigate which clinical and demographic features
were associated with patients' starting states. In the interest of
parsimony and statistical power, post hoc comparisons were per-
formed between the three subtypes that encompassed most of the
sample (>85%).
TABLE 1 Sample characteristics (N = 8380)
Characteristics Descriptive statistics
Age (mean, SD) 39.09 (13.94)
Gender (% male) 35.0
Ethnicity (% White British) 76.8




Self‐reported LTC (% with LTC) 29.0
Baseline PHQ‐9 score (mean, SD) 15.81 (6.27)
Baseline GAD‐7 score (mean, SD) 13.34 (5.40)
Baseline WSAS score (mean, SD) 20.85 (9.85)
Abbreviations: GAD‐7, Generalized Anxiety Disorder‐7; LTC, long‐term
health condition or illness; PHQ‐9, Patient Health Questionnaire‐9;
WSAS, Work and Social Adjustment Scale.
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3 | RESULTS
3.1 | Optimal depressive states model
The HMM analysis produced an optimal model with 14 separate
depressive states, each exhibiting different symptom‐profiles and
levels of severity. Figure 1 displays the overall mean score and a plot
of the corresponding intensity of each PHQ‐9 item for all 14 states.
State 1 displayed a profile of minimal symptoms with very low se-
verity. States 2, 4, 6, and 10 showed similar symptom‐profiles at
differing overall severities, with peak intensity on PHQ‐9 items 3, 4,
and 5, representing somatic symptoms. We therefore considered
these to belong to an overarching somatic depression subtype. States
3, 5, and 11 also displayed similar symptom‐profiles with different
levels of severity, but with patterns of peak intensity on items 1, 2,
and 6, representing cognitive‐affective symptoms. We considered
these to belong to an overarching cognitive‐affective depression
subtype. States 7, 8, 9, 12 and 13 all showed relatively even intensity
across most items (1–8) for different levels of severity; we con-
sidered these to belong to an overarching typical depression subtype.
However, there was a further distinction between the symptom‐
profiles of states 8 and 13 and states 9 and 12, with the latter two
states showing greater intensity on the suicidal risk item (item 9). We
therefore draw a further distinction between low‐risk typical (8, 13)
and high‐risk typical (9, 12) subtypes (7 being a typical state with
moderate‐risk). Finally, state 14 displayed a severe depressive state
with high severity across all items. Overall, the majority (87.5%) of
patients' starting states were classified into three broad subtypes
(cognitive‐affective, 23.7%; somatic, 21.4%; and typical, 42.4%).
Inspection of probable states over time was achieved through
the visualization of within and between‐state transitions. First,
Figure 2 presents stacked area plots for each starting state, showing
the probable states those patients will be in at each subsequent
treatment session. Across each figure, it is evident that most patients
remain in their starting state over time, and relatively small pro-
portions of patients transitioned into different states over the course
of therapy.
Figure 3 depicts the range of transition probabilities within and
between‐states during CBT, displaying the most likely between‐state
transitions. In general, the most probable between‐state transitions
were to a state of a similar symptom‐profile but with lower symptom
severity. Patients that started treatment in a cognitive‐affective or
somatic state tended to transition to another state within the same
overreaching cluster (i.e., somatic to somatic). There were a small
proportion of cross‐state cognitive‐affective to somatic transitions
from state 11 to 10 and from state 5 to 4, but almost no prominent
F IGURE 1 Depressive state profiles for the optimal 14‐state model. PHQ‐9, Patient Health Questionnaire‐9
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transitions in the opposite direction (i.e., from somatic to cognitive‐
affective).
The most severely depressed patients appeared to be most
likely to transition into the two typical states, either low‐risk typical
(states 8 and 13) or high‐risk typical (states 9 and 12). However,
there were rarely any crossover transitions between these two
states, with patients merging into state 7 when symptoms were at a
subthreshold severity. Similar trends were seen within the small
number of cases who experienced deterioration in their symptoms,
with transitions to higher severity states within the same symptom
cluster (e.g., state 3–5; state 8–13; state 9–12). Interestingly there
were no prominent deterioration transitions within the somatic
states.
3.2 | Relationship between clinical outcomes,
demographics, and depressive states
3.2.1 | Comparing somatic, cognitive‐affective, and
typical depression subtypes
Significantly different patterns of engagement (χ2 = 17.802, p < .001)
and number of sessions attended (F(2,7328) = 6.093, p = .002) were
observed across subtypes. Patients starting treatment in typical
states had significantly lower rates of engagement than
cognitive‐affective states and attended significantly fewer sessions
(p = .002). Comparisons between typical and somatic states (p = .729)
and cognitive‐affective and somatic states (p = .056) were not sig-
nificant. Of those who engaged in treatment (n = 6364), patients in
somatic and typical states were found to have significantly lower
rates of reliable improvement than those in cognitive‐affective
states, but did not differ from each other (χ2 = 13.764, p = .001).
Rates of deterioration did not differ between the three depression
subtypes (χ2 = 1.121, p = .571). Significantly more patients in the ty-
pical states dropped out of treatment compared to the cognitive‐
affective and somatic states (χ2 = 15.047, p = .001).
Six demographic variables were significantly associated with
starting treatment in a somatic state (relative to a cognitive‐affective
state) (χ2 = 239.57, p < .001, Nagelkerke R2 = 0.127). Patients with
somatic subtypes were more likely to be females from a white British
background, with a long‐term physical illness, additionally having
pharmacotherapy, and who had lower baseline depression and an-
xiety severity (Table 2).
Analyses comparing patients entering treatment in typical states
with differing risk profiles (low vs. high‐risk) and for states with si-
milar elevated risk scores, but differing state profiles (high‐risk ty-
pical vs. high‐risk cognitive‐affective) are reported in the
Supplemental Material and indicate that high‐risk typical subtypes
had lower dropout rates compared to low‐risk typical and high‐risk
cognitive‐affective subtypes.
F IGURE 2 Depressive state transitions in response to cognitive behavioral treatment (CBT) based on the 14 starting states. PHQ‐9, Patient
Health Questionnaire‐9
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4 | DISCUSSION
4.1 | Summary of findings
This large (N = 8380) multi‐service cohort study identified a total of 14
depressive states based on the combination of symptoms that patients
endorsed on the PHQ‐9 during the course of CBT. Grouping qualita-
tively similar states together resulted in an overarching framework of
five broad depression subtypes: mild (2.7%), severe (9.8%), cognitive‐
affective (23.7%), somatic (21.4%), and typical (42.4%). These subtypes
had high temporal stability, and the most common transitions during
treatment were from severe toward milder states within the same
overarching subtype. We also found that state transitions denoting a
deterioration of symptom‐severity occurred predominantly within the
cognitive‐affective and typical subtypes. Some cases transitioned to
other subtypes, but the probability tended to be low (<20%).
Post‐hoc comparisons of indicators of treatment engagement
and outcomes revealed that these depression subtypes do not
merely have descriptive value, but also have prognostic utility. As
shown in Table 3, symptom‐states characterized by moderate‐to‐
severe levels of depression (8, 9, 10, 11) showed the highest rates of
reliable improvement (>60%). States 1 and 2 had the lowest im-
provement rates (<31%), though these had the lowest baseline se-
verity, so this is likely to be a floor effect (i.e., little room for
improvement). Deterioration rates were generally low (<10%) across
all states, with the highest probability (9.6%) observed for state 7
and the lowest (0.5%) for state 14—although a ceiling effect is likely
for the latter. The four states with highest depression severity
(11–14) also had the highest dropout rates (>35%). Comparisons
between overarching depression subtypes revealed that patients
with a cognitive‐affective subtype were more likely to engage, at-
tended more sessions, and attain reliable improvement compared to
the typical and somatic subtypes. Patients with a typical subtype
were more likely to drop out of treatment compared to those with
cognitive‐affective and somatic subtypes. Furthermore, cases in the
high‐risk typical subtype had lower dropout rates compared to the
low‐risk typical subtype and the cognitive‐affective subtype cases
with comparably acute suicidal risk.
F IGURE 3 Within and between‐state transition probabilities in response to CBT; the range of probabilities over the course of treatment are
reported for each transition; p < .05 at more than half the time points are hidden; thickness of the arrow depicts the magnitude of the
probability, with thicker arrows representing more likely transitions; states are color coded accordingly–green = somatic, pale
orange = cognitive‐affective, blue = typical, pale blue = typical with low‐risk and dark blue = typical with high‐risk. CBT, cognitive behavioral
treatment
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4.2 | Wider empirical context
Previous empirical studies using the PHQ‐9 have proposed that
these symptoms load onto distinctive cognitive‐affective and somatic
factors, particularly in studies that included participants with co-
morbid physical illnesses/chronic health problems (e.g., Chilcot
et al., 2013; Doi et al., 2018; Krause et al., 2010). Approximately 29%
of our sample reported comorbid long‐term health problems, and this
was one of the significant features that characterized the somatic
depression subtype. However, studies specifically seeking to identify
depressive subtypes using data‐driven LCA have thus far yielded
mixed and inconclusive results (see review by Ulbricht et al., 2018).
Methodological advances, such as LTA have rarely been applied in
the wider field of mental health (e.g., McElroy et al., 2017; Rodgers
et al., 2014; Ulbricht et al., 2016), and less so in the specific field of
CBT for depression. Like other studies (e.g., Rodgers et al., 2014) we
found that gender played a role in determining class membership. In
the present sample, females were more likely to have the somatic
depression subtype whereas males were more likely to have the
cognitive‐affective subtype. Within the majority class of typical de-
pression, males were more likely to have acute suicidal risk. Of those
that exhibited high‐levels of suicidal risk, females were more likely to
have a cognitive‐affective subtype whereas males were more likely
to have a typical subtype.
To our knowledge, the study by Catarino et al. (2020) was the
first application of LTA in a large clinical sample of depressed pa-
tients accessing internet‐enabled CBT, albeit in an atypical format.
Our findings show remarkable similarities. Catarino et al. (2020) also
found distinctive states that clustered around three overarching
subtypes characterized by cognitive‐affective, somatic and “hybrid”
(typical) depression symptoms. Those with the somatic subtype had
lower indices of engagement and improvement, and were more likely
to be females, with comorbid long‐term health conditions who were
taking prescribed pharmacotherapy. The temporal stability of these
subtypes and their transition patterns were also highly similar. Most
transitions occurred toward lower severity states within the same
overarching subtype, and cross‐class transitions from “hybrid” (ty-
pical) to somatic subtypes were more likely than transitions from
“hybrid” to cognitive‐affective subtypes. Taken together, our findings
show strong evidence of replication and generalizability of these
depression subtypes and their prognostic utility across different
studies and different treatment samples receiving internet‐enabled
and more traditional (in‐person) CBT.
4.3 | Strengths, limitations, and future directions
This study used a large and adequately powered sample, covering
multiple regions of England, thus enhancing the external validity and
generalizability of findings to a typical population of patients ac-
cessing CBT in routine care. Relative to other cluster methods, LTA is
a state‐of‐the‐art method that makes best use of time‐series data
simultaneously enabling the modeling of symptom‐states, their
temporal stability and transition probabilities to other states
(Bartolucci et al., 2017). In addition, our sample selection, modeling
strategy, outcome measures and outcome definitions were closely
aligned to prior research (Catarino et al., 2020), thus enabling direct
comparability.
TABLE 2 Logistic regression analyses
examining the association between
patient demographics and starting state
for somatic versus cognitive‐affective
state comparisons
Predictor variable Mean (SD)/prevalence b SE Wald p





Baseline PHQ‐9 score 13.97 (5.46) 11.35 (4.06) 0.92 0.01 60.78 <.001***
Baseline GAD‐7 score 12.29 (4.93) 10.37 (4.93) 0.02 0.01 7.48 .006**
Baseline WSAS score 19.17 (9.17) 16.10 (8.21) 0.01 0.01 3.31 .069
Age (years) 38.43 (14.84) 38.14 (14.35) 0.01 0.00 3.45 .063
Gender (% male) 36.1 27.1 0.52 0.09 31.05 <.001***
Ethnicity (% White British) 79.4 83.7 −0.24 0.11 4.72 .030*
Employment (% unemployed) 26.8 20.8 0.12 0.10 1.48 .223
Medication (% prescribed
pharmacotherapy)
43.6 45.9 −0.19 0.08 4.59 .032*
Self‐report LTC (% with LTC) 28.8 33.2 −0.40 0.09 17.14 <.001***
Note: A positive relationship signifies that the variable is more likely to occur in patients entering
treatment in a cognitive‐affective state. Continuous variables were mean centered. Reference
categories for categorical variables: gender “female,” ethnicity “minority,” employment “employed,”
medication “not prescribed pharmacotherapy,” self‐report LTC “no LTC.”
Abbreviations: GAD‐7, Generalized Anxiety Disorder‐7; LTC, long‐term health condition or illness;
PHQ‐9, Patient Health Questionnaire‐9; WSAS, Work and Social Adjustment Scale.
*p < .05; **p < .01; ***p < .001.
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Despite these strengths, these findings should be interpreted in
light of some limitations. The depression subtypes identified in this
study are inevitably constrained by the limited number and specific
type of items contained in the PHQ‐9. Other studies using LTA on
different measures have reported different concepts and symptom‐
patterns, for example an atypical depression subtype associated with
eating disorder and psychotic symptoms (e.g., Rodgers et al., 2014).
Outcomes were defined using patient‐reported symptom measures,
and no formal diagnoses or observer‐rated outcomes were available.
Furthermore, outcomes could only be defined based on end‐of‐
treatment measures, so the longer‐term prognosis of patients with
different subtypes remains unclear.
Despite these caveats, the replicated evidence from this and a
previous study (Catarino et al., 2020) offer actionable clinical in-
sights. The subtyping algorithm could be prospectively applied to
routinely‐collected depression scores from new patients starting
treatment to classify them according to their latent depression
profiles. Patients with depression subtypes that have higher chances
of dropout and lower chances of symptomatic improvement could be
identified as early as the first therapy session and prioritized for
clinical supervision. In particular, patients with somatic depression,
who have comorbid illnesses may benefit from integrated care from
medical and psychological specialists (Naylor et al., 2016). The pre-
sent evidence, however, is specific to CBT and the generalizability of
these depression subtypes and treatment response patterns to other
forms of psychological or pharmacological treatment is unknown.
Replications of this method in clinical samples accessing different
treatments could help to advance future insights for personalized
treatment planning.
5 | CONCLUSION
Replicated evidence indicates that depression is a heterogeneous
condition characterized by several subtypes which are stable over
time, which are more likely to change in severity but less likely to
transition into other subtypes, and which show differential treatment
engagement and response patterns.









rate (%)a Improvement (%)a Deterioration (%)a
1. Mild 229 1.50 (1.19) 3.33 (2.71) 60.7 19.4 28.3 3.6
2. Somatic 155 4.42 (1.41) 4.84 (3.04) 78.1 17.4 30.8 2.5
3. Cognitive‐affective 377 5.47 (1.61) 5.21 (2.95) 83.8 18.0 55.4 3.8
4. Somatic 385 8.80 (1.70) 5.24 (2.94) 86.2 27.1 50.2 4.3
5. Cognitive‐affective 687 12.16 (2.51) 5.67 (2.90) 90.2 24.8 70.0 3.8
6. Somatic 396 9.40 (2.89) 4.93 (2.89) 84.1 25.5 57.1 5.2
7. Typical
(moderate‐risk)
343 9.86 (1.65) 5.16 (2.83) 86.3 21.3 55.5 9.6
8. Typical (low‐risk) 497 13.82 (1.71) 5.38 (2.82) 88.5 25.9 70.3 4.4
9. Typical (high‐risk) 588 16.86 (2.00) 5.43 (2.94) 88.1 28.4 64.7 5.1
10. Somatic 858 14.56 (2.34) 5.40 (2.82) 90.4 28.4 64.8 2.7
11. Cognitive‐affective 923 18.54 (2.70) 5.35 (2.82) 90.8 35.2 61.8 4.0
12. Typical (high‐risk) 974 22.36 (1.79) 4.83 (3.01) 81.1 35.8 52.4 1.2
13. Typical (low‐risk) 1148 19.39 (1.96) 5.17 (2.95) 85.7 36.4 59.1 1.7
14. Severe 820 24.53 (1.86) 4.72 (2.92) 81.1 36.5 47.6 0.5
Cognitive‐affective
(3, 5, & 11)
1987 13.83 (5.53) 5.43 (2.87) 89.3 28.5 63.6 3.9
Somatic (2, 4, 6 & 10) 1794 11.30 (4.07) 5.21 (2.88) 87.1 26.6 57.4 3.6
Typical (7, 8, 9, 12, & 13) 3550 18.10 (4.28) 5.14 (2.94) 85.3 31.9 58.2 3.2
Typical low‐risk (8 & 13) 1645 17.70 (3.17) 5.23 (2.91) 86.6 36.7 54.9 2.2
Typical high‐risk
(9 & 12)
1562 20.30 (3.25) 5.05 (2.99) 83.7 32.9 57.2 2.7
Abbreviation: PHQ‐9, Patient Health Questionnaire for major depressive disorder.
aPercentage within subset of treatment engagers.
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